Key result
Neural network model predicts cardiovascular disease with ~77% accuracy, performing comparably to SCORE2.
Why the study?
Given the significant global health impact of CVDs, the study aimed to assess the effectiveness of deep learning-based neural network models compared with traditional risk assessment methods like SCORE2.
Does an Artificial Neural Network model accurately predict cardiovascular disease risk compared to the SCORE2 risk assessment tool?
Does an Artificial Neural Network model accurately predict cardiovascular disease risk compared to the SCORE2 risk assessment tool?
An artificial neural network model demonstrated comparable accuracy to the established SCORE2 tool in predicting 10-year cardiovascular disease risk, highlighting the potential of machine learning in clinical risk assessment.
Neural network matches SCORE2 accuracy without significant differences; hypothesis-generating for machine learning in CVD risk prediction, pending validation.
This study introduces an approach to predicting cardiovascular diseases (CVDs) by leveraging neural networks and evaluates its performance against the widely recognized SCORE2 risk assessment tool. Given the significant global health impact of CVDs, our research aims to assess the effectiveness of deep learning‐based models compared with traditional methods. Our methodology involves developing and deploying a neural network model capable of learning intricate patterns and relationships from a comprehensive dataset. Leveraging a large population cohort with extended follow‐up enables precise and long‐term risk estimation. We utilize the T‐paired test to compare risk predictions between our neural network model and the SCORE2 tool. Our results indicate a notable accuracy of 0.77 for our neural network‐based model in predicting CVDs, with the T‐paired test revealing no significant variations in risk levels between the two methods. These findings underscore the effectiveness of neural networks as a robust tool for CVD risk prediction and advocate for further exploration and integration of these technologies to enhance cardiovascular risk assessment, thereby advancing predictive modeling in healthcare.
No takes yet. Share an insight, caveat, or question.
Saim et al. (2024) studied this question. The neural network model achieved an accuracy of 0.77 in predicting cardiovascular diseases, comparable to the SCORE2 risk assessment tool with no significant differences.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: